BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shatzel JJ, Taylor JA. Syndromes of Thrombotic Microangiopathy. Med Clin North Am 2017;101:395-415. [PMID: 28189178 DOI: 10.1016/j.mcna.2016.09.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Burwick RM, Moyle K, Java A, Gupta M. Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period. Hypertension 2021;78:760-8. [PMID: 34275337 DOI: 10.1161/HYPERTENSIONAHA.121.17311] [Reference Citation Analysis]
2 Zhou Y, Reilly SD, Gangaraju R, Reddy VVB, Marques MB. An Unusual Presentation of Thrombotic Thrombocytopenic Purpura. Am J Med 2017;130:e323-6. [PMID: 28528921 DOI: 10.1016/j.amjmed.2017.04.022] [Reference Citation Analysis]
3 Chung CH, Tsai IJ, Tseng MH, Chou HH, Tain YL, Tsai JD, Chiou YY, Chiou YH, Lin CY. Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan. Medicine (Baltimore) 2021;100:e25986. [PMID: 34011089 DOI: 10.1097/MD.0000000000025986] [Reference Citation Analysis]
4 Ponomareva AA, Nevzorova TA, Mordakhanova ER, Andrianova IA, Rauova L, Litvinov RI, Weisel JW. Intracellular origin and ultrastructure of platelet-derived microparticles. J Thromb Haemost 2017;15:1655-67. [PMID: 28561434 DOI: 10.1111/jth.13745] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
5 Filho JCCL, Ogawa MY, de Souza Andrade TH, de Andrade Cordeiro Gadelha S, Fernandes PFCBC, Queiroz AL, Daher EF. Spectrum of acute kidney injury associated with cocaine use: report of three cases. BMC Nephrol 2019;20:99. [PMID: 30894132 DOI: 10.1186/s12882-019-1279-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Vaidya A, Shastry S, Mohan G, Prethika PA. Role of Therapeutic Plasma Exchange in managing complement mediated thrombotic microangiopathy  - Case series. Transfus Clin Biol 2021:S1246-7820(21)00475-4. [PMID: 34628028 DOI: 10.1016/j.tracli.2021.10.001] [Reference Citation Analysis]
7 Enjeti AK, de Malmanche T, Chapman K, Ziolkowski A. Genomic investigation of inherited thrombotic microangiopathy-aHUS and TTP. Int J Lab Hematol 2020;42 Suppl 1:33-40. [PMID: 32543063 DOI: 10.1111/ijlh.13201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Murphree CR, Olson SR, Deloughery TG, Shatzel JJ. When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy. J Thromb Thrombolysis 2020;49:602-5. [DOI: 10.1007/s11239-020-02094-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Higuero Saavedra V, González-Calle V, Sobejano E, Sebastiá J, Cabrero M, Bastida JM, Puig N, Ocio EM, Mateos MV. Drug-induced Thrombotic Microangiopathy During Maintenance Treatment in a Patient With Multiple Myeloma. Hemasphere 2019;3:e192. [PMID: 31723829 DOI: 10.1097/HS9.0000000000000192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bergstrand M, Hansson E, Delaey B, Callewaert F, De Passos Sousa R, Sargentini-Maier ML. Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura. J Clin Pharmacol 2021. [PMID: 34699078 DOI: 10.1002/jcph.1991] [Reference Citation Analysis]
12 Azoulay E, Bauer PR, Mariotte E, Russell L, Knoebl P, Martin-Loeches I, Pène F, Puxty K, Povoa P, Barratt-Due A, Garnacho-Montero J, Wendon J, Munshi L, Benoit D, von Bergwelt-Baildon M, Maggiorini M, Coppo P, Cataland S, Veyradier A, Van de Louw A; Nine-i Investigators. Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 2019;45:1518-39. [PMID: 31588978 DOI: 10.1007/s00134-019-05736-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
13 Nasonov EL, Reshetnyak TM, Alekberova ZS. [Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]. Ter Arkh 2020;92:4-14. [PMID: 32598770 DOI: 10.26442/00403660.2020.05.000697] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Vigna E, Petrungaro A, Perri A, Terzi D, Recchia AG, Mendicino F, La Russa A, Bossio S, De Stefano L, Zinno F, Bonofiglio R, Morabito F, Gentile M. Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies. Transfus Apher Sci 2018;57:247-9. [PMID: 29567368 DOI: 10.1016/j.transci.2018.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
15 Bitzan M, Zieg J. Influenza-associated thrombotic microangiopathies. Pediatr Nephrol 2018;33:2009-25. [PMID: 28884355 DOI: 10.1007/s00467-017-3783-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
16 Murphree CR, Nguyen NN, Shatzel JJ, Olson SR, Chung PD, Lockridge JB, Andeen NK, DeLoughery TG. Biopsy-proven thrombotic microangiopathy without schistocytosis on peripheral blood smear: A cautionary tale. Am J Hematol 2019;94:E234-7. [PMID: 31175815 DOI: 10.1002/ajh.25551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Blasco M, Guillén E, Quintana LF, Garcia-Herrera A, Piñeiro G, Poch E, Carreras E, Campistol JM, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. Clin Kidney J 2021;14:1055-66. [PMID: 33841853 DOI: 10.1093/ckj/sfaa195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: Differential diagnosis. Pregnancy Hypertens 2018;12:29-34. [PMID: 29674195 DOI: 10.1016/j.preghy.2018.02.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
19 Hill KM, Moorman D, Mack J, Gonsalves C, Khalife R. A case of acute pancreatitis-induced microangiopathic hemolytic anemia with thrombocytopenia. J Thromb Thrombolysis 2020;49:159-63. [PMID: 31493291 DOI: 10.1007/s11239-019-01946-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Hollifield AL, Arnall JR, Moore DC. Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura. Am J Health Syst Pharm 2020;77:1201-7. [PMID: 32588878 DOI: 10.1093/ajhp/zxaa151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Grand'Maison S, Lapinsky S. Insights into pregnancy associated and atypical hemolytic uremic syndrome. Obstet Med 2018;11:137-40. [PMID: 30214480 DOI: 10.1177/1753495X18780099] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Tanaka H, Horioka K, Yamamoto M, Asari M, Okuda K, Yamazaki K, Shimizu K, Ogawa K. Overproduction of thrombopoietin by BRAFV600E-mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis. Cancer Sci 2019;110:2748-59. [PMID: 31301081 DOI: 10.1111/cas.14130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Guirguis N, Rehman T, Shams Y, Gordon M, Mekhaiel E, Rozell S, Pandya M. SARS-CoV-2 Infection Inducing Immune Thrombocytopenic Purpura: Case Series. Ochsner J 2021;21:187-9. [PMID: 34239380 DOI: 10.31486/toj.20.0100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2503-12. [PMID: 32914535 DOI: 10.1111/jth.15009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
25 Bommer M, Wölfle-Guter M, Bohl S, Kuchenbauer F. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies. Dtsch Arztebl Int 2018;115:327-34. [PMID: 29875054 DOI: 10.3238/arztebl.2018.0327] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]